Octagon Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Octagon Therapeutics's estimated annual revenue is currently $2.5M per year.
- Octagon Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Octagon Therapeutics has 16 Employees.
- Octagon Therapeutics grew their employee count by 33% last year.
Octagon Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Biology | Reveal Email/Phone |
2 | Lab Manager | Reveal Email/Phone |
3 | Interim CSO | Reveal Email/Phone |
4 | Research Associate | Reveal Email/Phone |
Octagon Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $9.1M | 59 | -9% | N/A | N/A |
#10 | $16.6M | 107 | 3% | N/A | N/A |
What Is Octagon Therapeutics?
Discovering new medicines based on metabolic vulnerabilities in pathological cell populations. Underlying platform uses engineered growth conditions to highlight novel metabolic targets in disease-causing bacteria, lymphocytes, and metastasizing cancer cells. Lead programs in autoimmunity and infectious disease.
keywords:N/A
N/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 16 | 14% | $200M |
#2 | $0.6M | 16 | 0% | $4.3M |
#3 | $1.7M | 16 | 0% | N/A |
#4 | $1.4M | 16 | N/A | N/A |
#5 | $15M | 16 | N/A | N/A |